Center for Veterinary Medicine

Last updated
Center for Veterinary Medicine
Center for Veterinary Medicine logo.png
Agency overview
Agency executive
  • Steven Solomon, DVM, Director
Parent agency Food and Drug Administration
Website www.fda.gov/animal-veterinary

The Center for Veterinary Medicine (CVM) is a branch of the U.S. Food and Drug Administration (FDA) that regulates the manufacture and distribution of food, food additives, and drugs that will be given to animals. These include animals from which human foods are derived, as well as food additives and drugs for pets or companion animals. CVM is responsible for regulating drugs, devices, and food additives given to, or used on, over one hundred million companion animals, plus millions of poultry, cattle, swine, and minor animal species. Minor animal species include animals other than cattle, swine, chickens, turkeys, horses, dogs, and cats.

Contents

CVM monitors the safety of animal foods and medications. Much of the center's work focuses on animal medications used in food animals to ensure that significant drug residues are not present in the meat or other products from these animals.

CVM does not regulate vaccines for animals; these are handled by the United States Department of Agriculture [1]

History

In 1953, a Veterinary Medical Branch of the FDA was created within the Bureau of Medicine. [2] A separate Bureau of Veterinary Medicine (BVM) was established in 1965. [3] At this time, the BVM included a Division of Veterinary Medical Review, Division of Veterinary New Drugs, and a Division of Veterinary Research. [2] In 1970, the Division of Compliance and Division of Nutritional Sciences were added. The Bureau underwent reorganization in 1976 and in 1984, it was renamed the Center for Veterinary Medicine. [2] [3]

Dr. Steven Solomon, DVM became the Director of the Center in 2017. [4] [5] He received his Doctor of Veterinary Medicine (DVM) degree from The Ohio State University and a Master's in Public Health from Johns Hopkins University. [5] He succeeded Tracey Forfa, who had been acting director for a few months. [6] The previous director was Dr. Bernadette Dunham; she served as Director from 2008 to 2016. [6]

Mission and vision

The mission of the center is "protecting human and animal health" and the vision of the organization is "Excellence. Innovation. Leadership." [7] The organization works across multiple disciplines to promote public health.

Office structure

The Center for Veterinary Medicine is divided into six key offices.

The Office of the Director coordinates activities for the center and establishes policy in a wide variety of areas, including management, research, and compliance. [8] It directs the planning, programming, budgeting, and administrative support for the center. The Office of the Director is also responsible for approving New Animal Drug Applications and Abbreviated New Animal Drug Applications, approving the use of animal food additives, and reviewing submitted New Animal Drug Applications for effects on human health. [8] The Director serves as the spokesperson for the center's activities and is in contact with the public, industry, other government agencies, national organizations, and international organizations.

The Office of Management provides customer service, guidance, and education on the activities of the center. [9] Individuals in this office are in charge of managing strategic planning of the center's goals and priorities and serve as liaisons for specific facilities, programs, and services provided by the center. This office is also in charge of managing billing, information management and technology, talent development, and budget planning for the center. [9]

The Office of New Animal Drug Evaluation reviews information submitted by drug sponsors who are working to gain approval to manufacture and market animal drugs. [10] This office determines if an animal drug should be approved and ensures that the new drug meets four pillars: the drug product must be safe for both animals and humans, must be effective for its intended use, must be a quality manufactured product, and must be properly labeled with how to safely use, store, and handle the drug. [10] This office also ensures that these standards are maintained after the drug enters the marketplace. The office has eight divisions which each evaluate a different part of the drug review process. [10]

The Office of Surveillance and Compliance is in charge of regulating animal drugs and devices for their safety and effectiveness and also oversees animal food safety programs. [11] Members of this office include veterinarians, animal scientists, toxicologists, consumer safety officers, and other scientists. The Office helps inspect products, analyze samples of products, and reviews products that may be imported into the United States. [11] The Office conducts education and outreach about compliance, helps monitor adverse events and identify safety issues with animal drugs, animal food, and animal devices. The Office works to prevent and address any animal food hazards. If any safety concerns are found, this Office can issue product safety alerts, packaging label changes, recalls, or can withdrawal a product's approval. [11]

The Office of Research helps to develop new procedures for analyzing drugs, food additives, and contaminants. [12] The Office works to investigate how drugs are absorbed, distributed, metabolized, and excreted, and how different drugs impact the immunology or physiology of animals. This office also helps develop screening tests for foodborne diseases and screens for drug residues in food products. The Office is involved in many scientific areas of research including veterinary medicine, animal science, biology, chemistry, microbiology, epidemiology, and pharmacology. [12] The building that houses this Office is equipped with laboratories, animal facilities, and has specialized experimental equipment to conduct research.

The Office of Minor Use and Minor Species is the smallest office within the Center and handles "minor use" drugs, which are those that are intended for use in horses, dogs, cats, cattle, pigs, turkey, and chickens but are for diseases that do not occur very frequently, only impact a small geographic area, or are only impacted a small number of animals each year. [13] [14] This Office also handles issues pertaining to "minor species" which include animals such as zoo animals, parrots, ferrets, guinea pigs, sheep, goats, and honeybees. [13] This Office establishes and maintains the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species. [14] Outreach and education is also a significant part of this Office's activities.

Sources

PD-icon.svg This article incorporates public domain material from websites or documents of the United States Department of Health and Human Services .

Related Research Articles

<span class="mw-page-title-main">Food and Drug Administration</span> United States federal agency

The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.

Health Canada is the department of the Government of Canada responsible for national health policy. The department itself is also responsible for numerous federal health-related agencies, including the Canadian Food Inspection Agency (CFIA) and the Public Health Agency of Canada (PHAC), among others. These organizations help to ensure compliance with federal law in a variety of healthcare, agricultural, and pharmaceutical activities. This responsibility also involves extensive collaboration with various other federal- and provincial-level organizations in order to ensure the safety of food, health, and pharmaceutical products—including the regulation of health research and pharmaceutical manufacturing/testing facilities.

<span class="mw-page-title-main">Regulation of therapeutic goods</span> Legal management of drugs and restricted substances

The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as in Australia.

<span class="mw-page-title-main">Federal Food, Drug, and Cosmetic Act</span> Acts of the United States Congress

The United States Federal Food, Drug, and Cosmetic Act is a set of laws passed by the United States Congress in 1938 giving authority to the U.S. Food and Drug Administration (FDA) to oversee the safety of food, drugs, medical devices, and cosmetics. The FDA's principal representative with members of congress during its drafting was Charles W. Crawford. A principal author of this law was Royal S. Copeland, a three-term U.S. senator from New York. In 1968, the Electronic Product Radiation Control provisions were added to the FD&C. Also in that year the FDA formed the Drug Efficacy Study Implementation (DESI) to incorporate into FD&C regulations the recommendations from a National Academy of Sciences investigation of effectiveness of previously marketed drugs. The act has been amended many times, most recently to add requirements about bioterrorism preparations.

<span class="mw-page-title-main">New Drug Application</span> Request US FDA approve new medications

The Food and Drug Administration's (FDA) New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing. Some 30% or less of initial drug candidates proceed through the entire multi-year process of drug development, concluding with an approved NDA, if successful.

<span class="mw-page-title-main">Carbadox</span> Chemical compound

Carbadox is a veterinary drug that combats infection in swine, particularly swine dysentery.

In the experimental (non-clinical) research arena, good laboratory practice or GLP is a quality system of management controls for research laboratories and organizations to ensure the uniformity, consistency, reliability, reproducibility, quality, and integrity of products in development for human or animal health through non-clinical safety tests; from physio-chemical properties through acute to chronic toxicity tests.

<span class="mw-page-title-main">Clenbuterol</span> Chemical compound which aids breathing

Clenbuterol is a sympathomimetic amine used by sufferers of breathing disorders as a decongestant and bronchodilator. People with chronic breathing disorders such as asthma use this as a bronchodilator to make breathing easier. It is most commonly available as the hydrochloride salt, clenbuterol hydrochloride.

A food safety agency or food administration or Food Safety Authority is a government agency responsible for ensuring the safety, quality, and proper labeling of food products within a country or region. These agencies play a crucial role in protecting public health by establishing and enforcing regulations and standards to ensure that food produced, imported, processed, distributed, and sold is safe for consumption.

The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biologics and related products. Not all biologics are regulated by CBER. Monoclonal antibodies and other therapeutic proteins are regulated by the FDA Center for Drug Evaluation and Research (CDER).

<span class="mw-page-title-main">Center for Drug Evaluation and Research</span> US Food and Drug Administration division

The Center for Drug Evaluation and Research is a division of the U.S. Food and Drug Administration (FDA) that monitors most drugs as defined in the Food, Drug, and Cosmetic Act. Some biological products are also legally considered drugs, but they are covered by the Center for Biologics Evaluation and Research. The center reviews applications for brand name, generic, and over the counter pharmaceuticals, manages US current Good Manufacturing Practice (cGMP) regulations for pharmaceutical manufacturing, determines which medications require a medical prescription, monitors advertising of approved medications, and collects and analyzes safety data about pharmaceuticals that are already on the market.

The Center for Food Safety and Applied Nutrition is the branch of the United States Food and Drug Administration (FDA) that regulates food, dietary supplements, and cosmetics, as opposed to drugs, biologics, medical devices, and radiological products, which also fall under the purview of the FDA.

Numerous governmental and non-governmental organizations have criticized the U. S. Food and Drug Administration for alleged excessive and/or insufficient regulation. The U.S. Food and Drug Administration (FDA) is an agency of the United States Department of Health and Human Services and is responsible for the safety regulation of most types of foods, dietary supplements, drugs, vaccines, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics. The FDA also enforces section 361 of the Public Health Service Act and the associated regulations, including sanitation requirements on interstate travel as well as specific rules for control of disease on products ranging from animals sold as pets to donations of human blood and tissue.

<span class="mw-page-title-main">Office of Global Regulatory Operations and Policy</span>

The Office of Global Regulatory Operations and Policy (GO), also known as the Office of Regulatory Affairs (ORA), is the part of the U.S. Food and Drug Administration (FDA) enforcing the federal laws governing biologics, cosmetics, dietary supplements, drugs, food, medical devices, radiation-emitting electronic devices, tobacco products, and veterinary medicine products which may have potentially harmful side effects for the consumer.

Biodyl is a trademark of Merial for a dietary supplement used in animals. It is manufactured in two formulations: a powder for use in an individual animal's drinking water, and an injectable solution. The injectable solution is available by veterinary prescription in some countries and over the counter in others.

The United States is the largest grower of commercial crops that have been genetically engineered in the world, but not without domestic and international opposition.

An animal drug refers to a drug intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals.

<span class="mw-page-title-main">Michael R. Taylor</span> American politician

Michael R. Taylor is an American lawyer who has played leadership roles in the US Food and Drug Administration, agrochemical company Monsanto, and law firm King & Spalding. He currently co-chairs the board of STOP Foodborne Illness, a non-profit that supports victims of serious illness and their families in efforts to strengthen food safety culture and practices in government and industry.

The National Drug Authority (NDA) is a government-owned organisation in Uganda, mandated to regulate drugs in the country, including their manufacture, importation, distribution, and licensing.

<span class="mw-page-title-main">Food safety in the United States</span>

Food safety in the United States relates to the processing, packaging, and storage of food in a way that prevents food-borne illness within the United States. The beginning of regulation on food safety in the United States started in the early 1900s, when several outbreaks sparked the need for litigation managing food in the food industry. Over the next few decades, the United States created several government agencies in an effort to better understand contaminants in food and to regulate these impurities. Many laws regarding food safety in the United States have been created and amended since the beginning of the 1900s. Food makers and their products are inspected and regulated by the Food and Drug Administration and the Department of Agriculture.

References

  1. ↑ Hill, R.E. Jr.; Foley, P.L.; Clough, N.E.; Ludemann, L.R.; Murtle, D.C. (2013). "Translating Research into Licensed Vaccines and Validated and Licensed Diagnostic Tests". In Roth, J.A.; Richt, J.A.; Morozov, I.A. (eds.). Vaccines and diagnostics for transboundary animal diseases: Ames, Iowa, 17-19 September 2012. Karger Medical and Scientific Publishers. pp. 53–54. ISBN   9783318023664.
  2. 1 2 3 Medicine, Center for Veterinary (2020-10-30). "History of CVM". FDA.
  3. 1 2 Plumlee, Konnie (2004). "Chapter 5. Regulatory toxicology". Clinical Veterinary Toxicology. Mosby. p. 29. ISBN   9780323011259.
  4. ↑ Commissioner, Office of the. "FDA Organization - Meet Dr. Steven Solomon, Director, Center for Veterinary Medicine". www.fda.gov. Retrieved 2019-04-05.
  5. 1 2 Medicine, Center for Veterinary (2021-02-08). "Steven Solomon". U.S. Food and Drug Administration. Retrieved 2021-05-23.
  6. 1 2 "Solomon is new FDA CVM director". American Veterinary Medical Association. February 15, 2017. Retrieved 30 June 2019.
  7. ↑ Medicine, Center for Veterinary (2020-10-07). "CVM Vision and Mission". FDA. Retrieved 2021-05-23.
  8. 1 2 Medicine, Center for Veterinary (2020-10-07). "Office of the Director". FDA. Retrieved 2021-05-23.
  9. 1 2 Medicine, Center for Veterinary (2020-10-29). "Office of Management". FDA. Retrieved 2021-05-23.
  10. 1 2 3 Medicine, Center for Veterinary (2021-02-08). "Office of New Animal Drug Evaluation". FDA. Retrieved 2021-05-23.
  11. 1 2 3 Medicine, Center for Veterinary (2021-04-15). "Office of Surveillance and Compliance". FDA. Retrieved 2021-05-23.
  12. 1 2 Medicine, Center for Veterinary (2020-09-02). "Office of Research". FDA. Retrieved 2021-05-23.
  13. 1 2 Medicine, Center for Veterinary (2021-02-16). "Minor Use/Minor Species". FDA. Retrieved 2021-05-23.
  14. 1 2 Medicine, Center for Veterinary (2021-02-16). "Office of Minor Use and Minor Species". FDA. Retrieved 2021-05-23.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.